Tumor necrosis factor

Tofacitinib Linked to Higher Risk of Major Adverse Cardiac Events in People with Rheumatoid Arthritis

Medicine & Technology Nov 11, 2021

Data recently showed that Tofacitinib is linked to statistically higher cases of major adverse cardiac events compared to TNF inhibitors, in people suffering from rheumatoid arthritis at an increased risk of cardiac occurrences.

Periodic Fever Syndrome Can Get Treated With Tumor Necrosis Factor, an FDA-Approved Medicine

Aug 19, 2021

Researchers recently discovered how the absence of protein can lead to a treatable autoinflammatory disease through tumor necrosis factor or TNF.

Tumor necrosis factor

Tofacitinib Linked to Higher Risk of Major Adverse Cardiac Events in People with Rheumatoid Arthritis

Periodic Fever Syndrome Can Get Treated With Tumor Necrosis Factor, an FDA-Approved Medicine

Most Popular

How Technology Is Changing the Real Estate Industry?

Study Reveals High Turnover in Scientific Research Careers: What This Means for Future Scientists

Nikolay Karpenko Biography, Photo, Career, Accomplishments

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

China’s Tiangong Space Station to Expand Its Capabilities With New Modules

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission